Kate Flanders

Kate Flanders serves as the Sr. Director of Strategic Account Business Development at Labcorp, where expertise lies in directing pharmaceutical and biologic drug development from discovery to IND, particularly in GLP and non-GLP nonclinical studies, bioanalytical, and drug metabolism. With a robust background in business development at Covance, Kate provided solutions for various early development services and managed client needs across multiple states. Previous roles include ensuring operational efficiency as Sr. Manager of Business Operations in Immunochemistry and coordinating customer satisfaction programs. Kate began a career in genetic toxicology, progressing from a Technician to Laboratory Manager at SITEK Research Laboratories. Kate holds a Master of Science in Technology Management from the University of Maryland Global Campus and a Bachelor of Science in Environmental Science from Virginia Tech.